Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126923991 | 12692399 | 1 | I | 20160822 | 20160828 | 20160828 | EXP | PHHY2016ES115273 | NOVARTIS | SANCHEZ-ORTEGA I, PARODY R, SERVITJE O, MUNIESA C, ARNAN M, PATINO B ET AL.. IMATINIB AND DASATINIB AS SALVAGE THERAPY FOR SCLEROTIC CHRONIC GRAFT-VS-HOST DISEASE. CROATIAN MEDICAL JOURNAL. 2016;57:247-54 | 0.00 | A | M | Y | 0.00000 | 20160829 | OT | ES | ES |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126923991 | 12692399 | 1 | PS | CICLOSPORIN | CYCLOSPORINE | 1 | Unknown | 3 MG/KG, QD | U | 50574 | 3 | MG/KG | QD | ||||||
| 126923991 | 12692399 | 2 | SS | CICLOSPORIN | CYCLOSPORINE | 1 | U | 50574 | |||||||||||
| 126923991 | 12692399 | 3 | SS | CICLOSPORIN | CYCLOSPORINE | 1 | U | 50574 | |||||||||||
| 126923991 | 12692399 | 4 | SS | IMATINIB | IMATINIB | 1 | Unknown | 100 MG, QD | 0 | 100 | MG | QD | |||||||
| 126923991 | 12692399 | 5 | SS | IMATINIB | IMATINIB | 1 | 0 | ||||||||||||
| 126923991 | 12692399 | 6 | SS | MYCOPHENOLATE MOFETIL. | MYCOPHENOLATE MOFETIL | 1 | Unknown | 1 G, Q8H | U | 0 | 1 | G | Q8H | ||||||
| 126923991 | 12692399 | 7 | SS | MYCOPHENOLATE MOFETIL. | MYCOPHENOLATE MOFETIL | 1 | U | 0 | |||||||||||
| 126923991 | 12692399 | 8 | SS | MYCOPHENOLATE MOFETIL. | MYCOPHENOLATE MOFETIL | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126923991 | 12692399 | 1 | Stem cell transplant |
| 126923991 | 12692399 | 2 | Prophylaxis against graft versus host disease |
| 126923991 | 12692399 | 3 | Immunosuppressant drug therapy |
| 126923991 | 12692399 | 4 | Chronic graft versus host disease |
| 126923991 | 12692399 | 5 | Chronic graft versus host disease in skin |
| 126923991 | 12692399 | 6 | Stem cell transplant |
| 126923991 | 12692399 | 7 | Prophylaxis against graft versus host disease |
| 126923991 | 12692399 | 8 | Immunosuppressant drug therapy |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126923991 | 12692399 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126923991 | 12692399 | Chronic graft versus host disease | |
| 126923991 | 12692399 | Chronic graft versus host disease in skin | |
| 126923991 | 12692399 | Neutropenia | |
| 126923991 | 12692399 | Off label use |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |